The “Intravenous
(IV) Iron Drugs – Global Strategic Business Report” report has
been added to ResearchAndMarkets.com’s offering.
The report provides separate comprehensive analytics for the US, Canada,
Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual
estimates and forecasts are provided for the period 2016 through 2024.
Also, a five-year historic analysis is provided for these markets.
This report analyzes the worldwide markets for Intravenous (IV) Iron
Drugs in US$ Thousand.
The report profiles 21 companies including many key and niche
players such as:
Key Topics Covered
1. GLOBAL MARKET OVERVIEW
2. GROWTH DRIVERS & MARKET TRENDS
3. REGULATORY OVERVIEW
4. OVERVIEW OF INTRAVENOUS (IV) IRON DRUGS
5. RECENT INDUSTRY ACTIVITY
6. FOCUS ON SELECT PLAYERS
7. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 21 (including Divisions/Subsidiaries
22)
The United States ((5)
Japan (2)
Europe (7)
– France (1)
– Germany (1)
– The United Kingdom (1)
– Rest of Europe (4)
Asia-Pacific (Excluding Japan) (8)
For more information about this report visit https://www.researchandmarkets.com/research/637g4n/global?w=4
View source version on businesswire.com: https://www.businesswire.com/news/home/20180618005490/en/
